Figure 3
From: Robotic image-guided reirradiation of lateral pelvic recurrences: preliminary results
The overall median survival after CyberKnife treatment was 11.5 months and 25.7 months after diagnosis of the pelvic recurrence. The actuarial one-year survival rate was 46%. The one-year actuarial local control rate was 51.4%. Median disease-free survival was 8.3 months after CyberKnife treatment.